[DNA-antibodies in patients with lupus erythematosus, scleroderma and blister-forming skin diseases].
D000645:Ammonium Sulfate; D000818:Animals; D000906:Antibodies / Q000032:analysis*; D001327:Autoimmune Diseases / Q000276:immunology; D001666:Binding Sites, Antibody; D003095:Collagen Diseases / Q000276:immunology; D004247:DNA / Q000276:immunology*; D003874:Dermatitis Herpetiformis / Q000276:immunology; D005260:Female; D005455:Fluorescent Antibody Technique / Q000379:methods; D006801:Humans; D008179:Lupus Erythematosus, Discoid / Q000276:immunology; D008180:Lupus Erythematosus, Systemic / Q000175:diagnosis / Q000276:immunology*; D051379:Mice / Q000276:immunology; D008875:Middle Aged; D010392:Pemphigus / Q000276:immunology; D011379:Prognosis; D012595:Scleroderma, Systemic / Q000276:immunology*; D012871:Skin Diseases / Q000276:immunology*; D014316:Tritium
D000906:Antibodies; D014316:Tritium; D004247:DNA; D000645:Ammonium Sulfate
DNS-Antikörper bei Patienten mit Lupus erythematodes, Sklerodermie und blasenbildenden Hautkrankheiten